These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 31693211)
1. L6H9 attenuates LPS-induced acute lung injury in rats through targeting MD2. Wu P; Yan H; Qi J; Jia W; Zhang W; Yao D; Ding C; Zhang Y; Chen M; Cai X Drug Dev Res; 2020 Feb; 81(1):85-92. PubMed ID: 31693211 [TBL] [Abstract][Full Text] [Related]
2. Chalcone derivatives ameliorate lipopolysaccharide-induced acute lung injury and inflammation by targeting MD2. Zhang YL; Zhang WX; Yan JQ; Tang YL; Jia WJ; Xu ZW; Xu MJ; Chattipakorn N; Wang Y; Feng JP; Liu ZG; Liang G Acta Pharmacol Sin; 2022 Jan; 43(1):76-85. PubMed ID: 34480112 [TBL] [Abstract][Full Text] [Related]
3. Targeting myeloid differentiation protein 2 by the new chalcone L2H21 protects LPS-induced acute lung injury. Zhang Y; Xu T; Wu B; Chen H; Pan Z; Huang Y; Mei L; Dai Y; Liu X; Shan X; Liang G J Cell Mol Med; 2017 Apr; 21(4):746-757. PubMed ID: 27860279 [TBL] [Abstract][Full Text] [Related]
4. Protective effects of hesperetin on lipopolysaccharide-induced acute lung injury by targeting MD2. Ye J; Guan M; Lu Y; Zhang D; Li C; Li Y; Zhou C Eur J Pharmacol; 2019 Jun; 852():151-158. PubMed ID: 30807747 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of myeloid differentiation factor 2 by baicalein protects against acute lung injury. Chen H; Zhang Y; Zhang W; Liu H; Sun C; Zhang B; Bai B; Wu D; Xiao Z; Lum H; Zhou J; Chen R; Liang G Phytomedicine; 2019 Oct; 63():152997. PubMed ID: 31254764 [TBL] [Abstract][Full Text] [Related]
6. Discovery of new MD2 inhibitor from chalcone derivatives with anti-inflammatory effects in LPS-induced acute lung injury. Zhang Y; Wu J; Ying S; Chen G; Wu B; Xu T; Liu Z; Liu X; Huang L; Shan X; Dai Y; Liang G Sci Rep; 2016 Apr; 6():25130. PubMed ID: 27118147 [TBL] [Abstract][Full Text] [Related]
7. Anti-inflammatory effects of novel curcumin analogs in experimental acute lung injury. Zhang Y; Liang D; Dong L; Ge X; Xu F; Chen W; Dai Y; Li H; Zou P; Yang S; Liang G Respir Res; 2015 Mar; 16(1):43. PubMed ID: 25889862 [TBL] [Abstract][Full Text] [Related]
8. Cardamonin inhibits LPS-induced inflammatory responses and prevents acute lung injury by targeting myeloid differentiation factor 2. Yang L; Luo W; Zhang Q; Hong S; Wang Y; Samorodov AV; Chattipakorn N; Pavlov VN; Liang G Phytomedicine; 2021 Dec; 93():153785. PubMed ID: 34638032 [TBL] [Abstract][Full Text] [Related]
9. Optimization and anti-inflammatory evaluation of methyl gallate derivatives as a myeloid differentiation protein 2 inhibitor. Qiu Y; Xiao Z; Wang Y; Zhang D; Zhang W; Wang G; Chen W; Liang G; Li X; Zhang Y; Liu Z Bioorg Med Chem; 2019 Oct; 27(20):115049. PubMed ID: 31466835 [TBL] [Abstract][Full Text] [Related]
10. Shikonin inhibits myeloid differentiation protein 2 to prevent LPS-induced acute lung injury. Zhang Y; Xu T; Pan Z; Ge X; Sun C; Lu C; Chen H; Xiao Z; Zhang B; Dai Y; Liang G Br J Pharmacol; 2018 Mar; 175(5):840-854. PubMed ID: 29243243 [TBL] [Abstract][Full Text] [Related]
11. Dexmedetomidine attenuates lipopolysaccharide induced acute lung injury in rats by inhibition of caveolin-1 downstream signaling. Liu J; Huang X; Hu S; He H; Meng Z Biomed Pharmacother; 2019 Oct; 118():109314. PubMed ID: 31545263 [TBL] [Abstract][Full Text] [Related]
12. Daidzein attenuates lipopolysaccharide-induced acute lung injury via toll-like receptor 4/NF-kappaB pathway. Feng G; Sun B; Li TZ Int Immunopharmacol; 2015 Jun; 26(2):392-400. PubMed ID: 25887269 [TBL] [Abstract][Full Text] [Related]
13. Flavokawain B alleviates LPS-induced acute lung injury via targeting myeloid differentiation factor 2. Luo W; Yang LB; Qian CC; Ma B; Manjengwa GM; Miao XM; Wang J; Hu CH; Jin B; Zhang LX; Zheng C; Liang G; Wang Y Acta Pharmacol Sin; 2022 Jul; 43(7):1758-1768. PubMed ID: 34737421 [TBL] [Abstract][Full Text] [Related]
14. Piperlongumine mitigates LPS-induced inflammation and lung injury via targeting MD2/TLR4. Tang Y; Zhang W; Wu L; Bai B; Zheng B; Li M; Tang Y; Zhu X; Zhang Y; Wang Y; Zhang B Biochem Biophys Res Commun; 2023 Jan; 642():118-127. PubMed ID: 36566563 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of Pendrin by a small molecule reduces Lipopolysaccharide-induced acute Lung Injury. Lee EH; Shin MH; Gi M; Park J; Song D; Hyun YM; Ryu JH; Seong JK; Jeon Y; Han G; Namkung W; Park MS; Choi JY Theranostics; 2020; 10(22):9913-9922. PubMed ID: 32929324 [No Abstract] [Full Text] [Related]
16. Inhibition Of JNK Phosphorylation By Curcumin Analog C66 Protects LPS-Induced Acute Lung Injury. Xiao Z; Xu F; Zhu X; Bai B; Guo L; Liang G; Shan X; Zhang Y; Zhao Y; Zhang B Drug Des Devel Ther; 2019; 13():4161-4171. PubMed ID: 31849448 [TBL] [Abstract][Full Text] [Related]
17. Growth hormone releasing peptide-2, a ghrelin agonist, attenuates lipopolysaccharide-induced acute lung injury in rats. Li G; Li J; Zhou Q; Song X; Liang H; Huang L Tohoku J Exp Med; 2010 Sep; 222(1):7-13. PubMed ID: 20805679 [TBL] [Abstract][Full Text] [Related]
18. Flavonoids from Radix Tetrastigmae improve LPS-induced acute lung injury via the TLR4/MD-2-mediated pathway. Liu DD; Cao G; Han LK; Ye YL; Zhang Q; Sima YH; Ge WH Mol Med Rep; 2016 Aug; 14(2):1733-41. PubMed ID: 27314522 [TBL] [Abstract][Full Text] [Related]
19. Nebulized Heparin Attenuates Pulmonary Coagulopathy and Inflammation through Alveolar Macrophages in a Rat Model of Acute Lung Injury. Chimenti L; Camprubí-Rimblas M; Guillamat-Prats R; Gomez MN; Tijero J; Blanch L; Artigas A Thromb Haemost; 2017 Nov; 117(11):2125-2134. PubMed ID: 29202212 [No Abstract] [Full Text] [Related]
20. Carbon Monoxide Attenuates Lipopolysaccharides (LPS)-Induced Acute Lung Injury in Neonatal Rats via Downregulation of Cx43 to Reduce Necroptosis. Li W; Wu F; Chen L; Li Q; Ma J; Li M; Shi Y Med Sci Monit; 2019 Aug; 25():6255-6263. PubMed ID: 31429423 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]